Search
Bausch + Lomb Corp
BLCOAdd to Watchlist
16.910USD
-0.090-0.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.99BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Bausch + Lomb Corp is 6.67, ranking 162 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 17.00, with a high of 21.00 and a low of 13.00.
Analyst Rating
Based on
12
analysts
Hold
Current Rating
18.545
Target Price
+14.48%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Bausch + Lomb Corp
BLCO
12
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Medtronic PLC
MDT
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bausch + Lomb Corp's expected revenue for the next quarter?
Bausch + Lomb Corp's expected revenue is 1.37B.
What is Bausch + Lomb Corp's price target?
Analysts forecast that Bausch + Lomb Corp's price target is USD 17.00, with the highest forecast at USD 21.00 and the lowest forecast at USD 13.00.
How have Bausch + Lomb CorpBLCO's recent earnings per share performed?
The market expectation was USD -0.04, while Bausch + Lomb CorpBLCO's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD 0.21.
What is the analyst rating for Bausch + Lomb Corp?
Based on the ratings of Bausch + Lomb Corp's stock from 12 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.